Delivery Order SPE2DB22D3501-SPE2DB25FUK20
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,365.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566669347 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract...
This federal contract award, valued at $2,893.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566612896 - ROPIVACAINE 0.2% 400 MG/200 ML 200ML, which is a pharmaceutical product. The contract has a ceiling value of $2,893.28 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This contract, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order for the provision of ROPIVACAINE 0.2% 400 MG/200 ML 200ML, a pharmaceutical product. The contract has a potential value of $7,077.65 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Ropivacaine 0.2% 400 mg/200 ml, a pharmaceutical product, with a potential value of $5,260.13 and a completion date of February 22, 2024. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,546.71 firm fixed price delivery order is for the pharmaceutical product 4563968966 - ROPIVACAINE 0.5% 150 MG/30 ML 30ML. The contract has an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,883.24 firm-fixed-price delivery order is for the supply of 4565878585 - Ropivacaine 0.2% 400 mg/200 ml medication. The contract has a period of performance through September 20, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office division is the prime contractor for this award. This delivery...
This federal contract award, identified as SPE2DB20D1109|SPE2DB23FP07K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,167.39 firm fixed-price delivery order is for the supply of 4560842389 ! ROPIVACAINE 0.5% 150 MG/30 ML 30ML, a medication used for pain management. The contract has an ultimate completion date of May 8, 2023 and was awarded on May 5, 2023. This award is associated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.38 Firm Fixed Price Delivery Order is for the supply of 4566736884 - ROPIVACAINE 0.2% 200 MG/100 ML 100ML, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a potential value of $4,158.00 and a completion date of February 21, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Ropivacaine 0.2% 400 mg/200 ml medical supplies. The contract, valued at $2,024.93, was awarded by the Defense Logistics Agency (DLA) on December 29, 2023, with a completion date of January 2, 2024. The contract is a Delivery Order under a firm fixed price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...